-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-chronic-kidney-rapid-research.pdf
November 01, 2024 - Primary studies: Data were extracted into tables for the following fields: first author, year, study … KQ1 and KQ2 characteristics of included SRs (all low quality)
Author Year;
# of Studies;
Total N; … of the Evidence
8
Author Year;
# of Studies;
Total N; CKD
Stage;
Periodontal
Condition; … of the Evidence
9
Author Year;
Country;
Funding Source;
CKD Stage
Quality
Design;
Total … No meta-
3.3.2 Results, Key Question 4, Detailed Description of the Evidence
25
Author Year;
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-draft-appendi-c.xlsx
January 01, 2024 - Characteristics of Included KQ 1 and KQ 2 RCTs
First Author Last Name, Year of Publication Citation … Intervention 2 Description Intervention 3 Description Intervention 4 Description Intervention 5 Description … Characteristics of Included KQ 1 and KQ 2 NRSIs
First Author Last Name, Year of Publication Citation … Outcomes of Included KQ 1 NRSIs
First Author Last Name, Year of Publication Citation Actual Followup … Outcomes of Included KQ 2 NRSIs
First Author Last Name, Year of Publication Citation Actual Followup
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research.pdf
March 01, 2018 - primary outcomes
3
Description of secondary outcome
Analysis Description of the pre-specified … or the year of study completion. … Description of the Identified Studies
Question 2. … Description of the Identified Studies
Question 2. … Description of the Identified Studies
Question 2.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-diabetes-rapid-research.pdf
November 01, 2024 - , Outcomes Detail
13
Author, Year;
Country;
Funding
Source;
DM Stage;
Quality
Design; … Statistically significant changes in outcomes in studies mapping to KQ2
Author Year;
Country;
N; … , Key Points
15
Author Year;
Country;
N;
Intervention vs
Control;
Study Design;
Quality … , Key Points
16
Author Year;
Country;
N;
Intervention vs
Control;
Study Design;
Quality … , Detailed
Description
23
Author Year;
Quality of SR;
Quality of
Included
Studies;
Certainty
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-risk-drugs-protocol.pdf
July 27, 2023 - Intervention RQs 1-4: Not applicable (description of harms
associated with anticoagulant use in the … Description of Included Studies
To efficiently describe eligible studies, the full text of each potentially … To describe eligible systematic reviews, a single team member will prepare a summary
including the author … , year, study design, number of study part... … To describe eligible systematic reviews, a single team member will prepare a summary including the author
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-glucose-control_research.pdf
July 01, 2010 - ...........................................................................................7
Author … Results
Description of the Cohort
We received data on 1,234,540 individuals meeting the broad criteria … Description of Individuals Using Exenatide by Treatment Period
In Table 1 is a description of the patients … Description of individuals with diabetes mellitus stratified by injectable medication use
Covariates … Description of individuals with diabetes mellitus stratified by injectable medication use (continued)
-
effectivehealthcare.ahrq.gov/sites/default/files/mental-illness-disparities_disposition-comments.pdf
May 26, 2016 - Comment Response
Peer Reviewer
#1
Findings I also thought that more information was needed on the description … We rearranged the report structure to add a description
of the findings to the beginning of the result … We have included a
description of and a citation for the DECIDE study in the
“Future Areas for Research … Peer Reviewer
#2
Background The Background was thorough in its description of the clinical
problem … Peer Reviewer
#4
Methods “Systematic review” may not be the most appropriate description of
this
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
September 01, 2011 - However, a
description of meta-analysis goes beyond
this report. … The description of industry funding has been
removed. … The description of industry funding has been
removed. … (Lovell, Reiff,
Jones, et al., 2006) or 8-year (Lovell, Reiff, Ilowite, et al., 2008 follow-
up. … However, the description of
methotrexate has been expanded.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/developing-consistent-useful-quality-improvement.pdf
September 01, 2020 - This report is made available to the public under the terms of a licensing agreement between the
author … Implementation
Strategies
No description No description No description No description No description … No description No description No description
28. … Organizational
History of
Change
No description No description No description No description No description … Fidelity
No description No description No description No description No description No description
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hnhc-disposition-comments.pdf
October 29, 2021 - high-utilizers-health-care/research
Published Online: October 29, 2021
2
Summary of Peer Reviewer Comments and Author … Changes included improving the description of the
inclusion/exclusion criteria in methods; more clearly … We
expanded our description of the realist review literature rigor assessment to better
explain how … high-utilizers-health-care/research
Published Online: October 29, 2021
5
Public Comments and Author … stakeholder interpretation of LCA and
k-means outputs, and demonstrates significant differences in 1-year
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/nursing-staff-shortages-rapid-research-appendix-c.xlsx
January 01, 2024 - Characteristics and outcomes of included systematic reviews
Author, Year Objectives/Aim Population Inclusion … of Participants, n Comparator Intervention Category Interventions Description Patient Safety Outcome … 2016–2017, 16.7% for the year 2017–2018, and 5.7% for the year 2018–2019. … Barriers, facilitators, and resources reported in primary studies
Author, Year Study Design Intervention … Author, Year Risk of Bias Judgment: Confounding Risk of Bias Judgment: Selection Risk of Bias Judgment
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/deprescribing-protocol.pdf
July 01, 2023 - Timing Original studies published from
2019 onwards, the year of the
search done for the MHS III report … reviewed by a single team member to confirm eligibility and prepare a summary of the study,
including author … , year, study design, number of study participants, and main findings relevant to
the review questions … To describe eligible systematic reviews, a single team member will prepare a summary including
the author … , year, number of studies by study design, and main findings relevant to each of our
review questions
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_surveillance.pdf
January 15, 2013 - Evidence Table
Study Description Intervention
Inclusion/Exclusion
Criteria/ Population Baseline … on a
protein-restricted diet and the
rest were on BH4.
97.7% of the early diagnosed
Study Description … Analysis of lifetime Phe data
showed that Phe levels at
ages 4, 5, and 6 accounted for
Study Description … within therapeutic targets and
a decrease in the values above
target…, and decreased the
Study Description … No studies identified
Study Description Intervention
Inclusion/Exclusion
Criteria/ Population
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
January 01, 2006 - Was there a clear description of the techniques used to identify the events?
5. … Was the description of the population adequate?
2. … Trials of rofecoxib vs NSAIDs
Author
year
Aspirin
permitted? … Trials of etoricoxib and lumiracoxib (Safety only)
Author
Year
Patient
masked? … Topical NSAIDs trials
External Validity
Author
Year
Patient
masked?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-surgical-report-cards.pdf
July 01, 2023 - • No outcome of interest
Timing Original studies published from
2011 onwards, the year of the … reviewed by a single team member to confirm eligibility and prepare a summary of
the study, including author … , year, study design, number of study participants, and main
findings relevant to the review questions … To describe eligible systematic reviews, a single team member will prepare a summary
including the author … , year, number of studies by study design, and main findings
relevant to each of our review questions
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendix-c-prepub-final.xlsx
January 01, 2025 - Table C-1 Characteristics of included studies KQ 3, KQ 4, and KQ 5
First Author Last Name Year of Publication … KQ 3 Outcomes (Accuracy)
First Author Last Name Year of Publication Study Design Cancer Type Analyte … KQ 5 Outcomes (Harms)
First Author Last Name Year of Publication KQ 5 Harm Outcomes
Lennon 2020 Of … Risk of bias of included studies for KQ 4 and KQ 5
First Author Last Name Year of Publication Is it … TACIT for systematic reviews in CQ 1
First Author Last Name Year of publication 1.1 Did any funders
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-final-app-c.xlsx
January 01, 2025 - Table C-1 Characteristics of included studies KQ 3, KQ 4, and KQ 5
First Author Last Name Year of Publication … KQ 3 outcomes (accuracy)
First Author Last Name Year of Publication Study Design Cancer Type Analyte … KQ 5 outcomes (harms)
First Author Last Name Year of Publication KQ 5 Harm Outcomes
Lennon 2020 Of … Risk of bias of included studies for KQ 4 and KQ 5
First Author Last Name Year of Publication Is it … TACIT for systematic reviews in CQ 1
First Author Last Name Year of Publication 1.1 Did any funders
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/asd-medical-disposition.pdf
May 26, 2017 - The excluded studies appendix is organized by year
and then alphabetically. … There is a short but
concise description of ASD and the problems associated with the
condition. … We did not set specific parameters for small,
medium, or large; we acknowledge that our
description … TEP Reviewer
#5
Results I am not sure from the description why melatonin is not low SOE. … Discussion/Conclu
sion
Finally, ref. 42 is not correct – it is to an RCT protocol by the same
author
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/making-healthcare-safer-IV.pdf
August 04, 2023 - In the United States,
more than 2.8 million antimicrobial-resistant infections occur each year and … Usual practice or other type of
PSP
• No concurrent or historical
comparison group
• No clear description … Description of Included Studies
To efficiently describe eligible studies, the full text of each potentially … reviewed by a single team member to confirm eligibility and prepare a summary of the study,
including author … To describe eligible systematic reviews, a single team member will prepare a summary including
the author
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/long-term-care-adults_disposition-comments.pdf
November 07, 2012 - We have revised the description of costs. … We have revised the description of costs. … We have revised the description of costs. … Organizing the table by author name makes the information hard to
use. … We have included a description of this.